Systemic Barriers

Breaking Down Barriers to Schizophrenia Treatment & Support On May 24, 2023, the Schizophrenia & Psychosis Alliance activated hundreds of people in our community to speak out and join our movement as we fight the discrimination against people with schizophrenia and psychosis disorders. To celebrate World Schizophrenia Day, we focused our Day of Action on […]

S&PAA Joins Schizophrenia Spectrum Biomarkers Consortium to Support Earlier Diagnosis, Development of New Treatments for Severe Brain Disease

April 5, 2023 – The Schizophrenia & Psychosis Action Alliance has joined the Schizophrenia Spectrum Biomarkers Consortium, organized by the Foundation for the National Institutes of Health to identify certain signs in the body that could help diagnose schizophrenia earlier and guide development of new treatments. Schizophrenia is one of the most disabling medical conditions, […]

About the Insight Initiative

S&PAA’s research program, launched in 2020, is designed to complement early-stage and clinical research into schizophrenia’s origins, diagnosis and treatment by delivering insights on the personal and societal impact of schizophrenia.

New Voice of the Patient Report showcases the urgent need for better schizophrenia treatments

Feb. 7, 2023 – The Schizophrenia & Psychosis Action Alliance and its partners today released the Voice of the Patient Report, which captures the powerful stories of people living with schizophrenia and those who care for them. The report summarizes the compelling testimony provided during the Nov. 2 Externally-Led Patient-Focused Drug Development meeting on schizophrenia, […]

Patient-Focused Treatment

Landmark Externally-Led Patient-Focused Drug Development Meeting on Schizophrenia Showcases Urgent Need for New & Better Treatments November 2 from 10 a.m. to 3 p.m. ET Access the Event Livestream Click Here Add This Event to Your Calendar The calendar invite below includes a link that will bring you back to this website for the livestream […]

Schizophrenia cost the U.S. $281.6 billion in 2020

Schizophrenia cost the U.S. $281.6 billion in 2020 Alexandria, VA – The Schizophrenia & Psychosis Action Alliance (S&PAA) today released “Societal Costs of Schizophrenia and Related Disorders,” a report that identifies the staggering direct and indirect costs of caring for the estimated 2.65 million people in the U.S. living with schizophrenia. The research, commissioned by […]

Action Script

Action Script Sample Federal Legislator Letter Sample State Legislator Letter Copy and paste the message(s) below to write your state and federal representatives. Download PDF version here.   Tip: Email or fax your letter to save time. You can also use it as a script to call legislators.   To find your United States Senator, […]

Societal Costs

Societal & Caregiver Costs of Schizophrenia & Related Disorders The direct and indirect costs of caring for people living with schizophrenia in the US are staggering. Our research details these costs, underscoring our country’s devastating failure to provide appropriate medical care for people living with schizophrenia. There is urgent need for policy changes to promote […]